Providence Investment Company Limited
15
7M
5
1.88
0.67
1
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main department of described VC is located in the Germany.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Definigen, evonetix, Phico Therapeutics. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Biopharma, Therapeutics.
Comparing to the other companies, this Providence Investment Company Limited performs on 19 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2013. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2014.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Providence Investment Company Limited, startups are often financed by UK Innovation & Science Seed Fund, Nesta Ventures, Morningside Venture Partners. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Morningside Venture Partners, Avlar BioVentures. In the next rounds fund is usually obtained by Morningside Venture Partners, Nesta Ventures, UK Innovation & Science Seed Fund.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 1.88
- Follow on index
- 0.67
- Investments by industry
- Biotechnology (15)
- Medical (9)
- Therapeutics (9)
- Biopharma (8)
- Health Care (4) Show 4 more
- Investments by region
-
- United Kingdom (15)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 76M
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
- Avg. multiplicator
- 10.93
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| evonetix | 07 Feb 2023 | Biotechnology, Life Science, Biopharma | Early Stage Venture | 27M | England, Uttlesford, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.